Pressmeddelanden - Organon AB
Här finner du pressmeddelanden som gavs ut av Organon AB innan sammanslagningen med Schering-Plough.
För 2009 finns inga pressmeddelanden från Organon AB. Vänligen, välj årtal nedan.
Välj år:
10 december 2004
1 december 2004
Nationellt pressmeddelande:
Kom ihåg NuvaRing® med e-post och sms
(Göteborg, Sverige): Att börja med ett nytt preventivmedel kräver ofta nya rutiner som ibland kan vara svåra att komma ihåg. På hemsidan www.p-ring.nu kan användare av den nya p-ringen NuvaRing kostnadsfritt ladda hem moderna tjänster i form av e-post- och sms-påminnelser som en hjälp för att komma ihåg att sätta in och ta ut NuvaRing.
30 november 2004
Internationellt pressmeddelande:
Organon investigates non-hormonal menopausal therapy for women suffering from hot flushes and (night)sweats
(Oss, The Netherlands): The initiation of Phase 2/3 studies announced by Organon today mark the development of a innovative non-hormonal approach to the treatment of hot flushes and (night)sweats in menopausal women. Two Moonstone trials will investigate the efficacy of a new type of drug known as Serotonin 2 Blockers (S2B) for the treatment of hot flushes; Org50081 is the first non-hormonal therapy to be systematically investigated in a randomized trial for the relief of vasomotor symptoms associated with the menopause.
4 oktober 2004
Internationellt pressmeddelande:
Ongoing trials will reveal that Livial® further improves quality of life without risk to postmenopausal women’s health - restoring confidence in postmenopausal women’s health
(Amsterdam, The Netherlands): Ongoing clinical studies discussed today will conclusively show whether Livial® (tibolone) further improves women’s quality of life without posing long-term health risks, particularly in relation to the breast, said Prof. Peter Kenemans, President of the Amsterdam Menopause Society (AMS).
31 augusti 2004
Internationellt pressmeddelande:
Akzo Nobel integrates Diosynth and Organon to reinforce its human pharmaceutical business
(Arnhem, The Netherlands): EUR 60 mln investment for new parenteral production facility in The Netherlands - New biotechnology research facility in the United States
Visar 1–5 av totalt 19 artiklar.
